Latest / Clinical Deep Dives / PSYCH 144: Gastrointestinal Disorders

Transcript

PSYCH 144: Gastrointestinal Disorders · Clinical Deep Dives

• 0:00
  SPEAKER_00: So think about it like this.
• 0:02
  SPEAKER_00: You break your arm, right?
• 0:04
  SPEAKER_00: And an x-ray proves it.
• 0:05
  SPEAKER_01: Yeah.
• 0:05
  SPEAKER_01: The evidence is right there.
• 0:06
  SPEAKER_00: Exactly.
• 0:07
  SPEAKER_00: The jagged white line is right there on the film.
• 0:10
  SPEAKER_00: And the orthopedic surgeon just points to it and says,
• 0:11
  SPEAKER_00: you know, there is the source of your pain.
• 0:14
  SPEAKER_01: It's very satisfying.
• 0:15
  SPEAKER_01: Very binary.
• 0:16
  SPEAKER_00: It is.
• 0:17
  SPEAKER_00: But what happens when a patient is screaming in agony,
• 0:20
  SPEAKER_00: they've had, I mean, 30 hospital admissions.
• 0:23
  SPEAKER_00: They've been subjected to every scan, scope, and biopsy known to modern medicine.
• 0:28
  SPEAKER_01: And every single result is perfectly clear.
• 0:30
  SPEAKER_00: Right.
• 0:31
  SPEAKER_00: Perfectly normal.
• 0:32
  SPEAKER_00: And yet,
• 0:33
  SPEAKER_00: if you look at the neuroimaging,
• 0:34
  SPEAKER_00: their brain is actually physically shrinking from the pain.
• 0:38
  SPEAKER_01: It's the ultimate diagnostic blind spot in modern medicine.
• 0:41
  SPEAKER_00: Today, we're tearing apart that old medical divide between what is,
• 0:44
  SPEAKER_00: quote unquote, real and what is in your head.
• 0:47
  SPEAKER_00: Because, as it turns out, that divide is a complete biological fiction.
• 0:52
  SPEAKER_01: Absolutely.
• 0:53
  SPEAKER_01: When we encounter that profound suffering without a,
• 0:56
  SPEAKER_01: you know,
• 0:56
  SPEAKER_01: a peripheral structural biomarker,
• 0:59
  SPEAKER_01: the whole biomedical model just completely collapses.
• 1:02
  SPEAKER_00: We're left with a massive population of disenfranchised patients
• 1:06
  SPEAKER_00: and deeply frustrated clinicians.
• 1:08
  SPEAKER_00: So welcome, everyone.
• 1:10
  SPEAKER_00: Whether you're a dedicated psychiatric trainee,
• 1:12
  SPEAKER_00: a seasoned clinician trying to manage a highly complex presentation on
• 1:16
  SPEAKER_00: the medical ward,
• 1:17
  SPEAKER_00: or just a motivated learner pushing the boundaries of your knowledge,
• 1:20
  SPEAKER_00: welcome to another deep dive.
• 1:22
  SPEAKER_01: Brilliant to be here.
• 1:23
  SPEAKER_00: Our objective today is to really forensically dismantle Chapter 27.3 of Kaplan
• 1:28
  SPEAKER_00: and Sadak Shear's Comprehensive Textbook of Psychiatry.
• 1:32
  SPEAKER_01: The gastrointestinal disorders chapter.
• 1:34
  SPEAKER_00: That's the one.
• 1:35
  SPEAKER_00: And our anchor for this entire analysis is this singular, unyielding principle.
• 1:40
  SPEAKER_00: Psychiatry is a study of how the brain,
• 1:43
  SPEAKER_00: the mind,
• 1:43
  SPEAKER_00: and human experience interact,
• 1:45
  SPEAKER_00: and crucially, how that intricate process can go catastrophically wrong.
• 1:49
  SPEAKER_01: And, you know,
• 1:50
  SPEAKER_01: to understand how it goes wrong in the context of GI disorders,
• 1:53
  SPEAKER_01: we really have to discard that linear,
• 1:56
  SPEAKER_01: unidirectional etiology we were all conditioned to accept in medical school.
• 1:59
  SPEAKER_00: Right, the idea that the gut just sends a signal up.
• 2:01
  SPEAKER_01: Exactly.
• 2:02
  SPEAKER_01: The idea that pathology starts in a peripheral organ and just sort of sends
• 2:06
  SPEAKER_01: a distress signal up to a passive brain, that's entirely obsolete now.
• 2:09
  SPEAKER_00: I want to introduce a conceptual framework here,
• 2:11
  SPEAKER_00: a sort of mental architecture for you to navigate this chapter.
• 2:15
  SPEAKER_00: Imagine, if you will, a sprawling neo-Victorian communication network.
• 2:20
  SPEAKER_01: I like this.
• 2:21
  SPEAKER_00: Picture Medlock Holmes stepping into a vast industrial space.
• 2:26
  SPEAKER_00: Let's call it the great gut-brain exchange.
• 2:29
  SPEAKER_00: The brain and the gastrointestinal tract are connected by this relentless barrage
• 2:33
  SPEAKER_00: of moving signals.
• 2:34
  SPEAKER_01: Yeah, just constantly chattering.
• 2:36
  SPEAKER_00: Right.
• 2:37
  SPEAKER_00: You have these heavy downward driving cables,
• 2:39
  SPEAKER_00: the autonomic nervous system,
• 2:40
  SPEAKER_00: the neuroendocrine pathways,
• 2:42
  SPEAKER_00: the HPA axis, and they're just shouting commands from the brain to the gut.
• 2:46
  SPEAKER_01: And surging up from the floor of this exchange,
• 2:49
  SPEAKER_01: traveling back towards the brain, is an equally dense thicket of upward traffic.
• 2:53
  SPEAKER_00: What does that look like?
• 2:54
  SPEAKER_01: Well, you have sensory afferents,
• 2:56
  SPEAKER_01: immune system cytokines,
• 2:58
  SPEAKER_01: hormonal cascades,
• 2:59
  SPEAKER_01: and microbial metabolites generated by literally troins of bacteria.
• 3:02
  SPEAKER_00: Wow.
• 3:03
  SPEAKER_01: The massive paradigm shift here is that there is no single direction of causation.
• 3:08
  SPEAKER_01: It is an unbroken,
• 3:09
  SPEAKER_01: reciprocal loop brain to gut to immune system to microbiome and
• 3:12
  SPEAKER_01: then right back again.
• 3:13
  SPEAKER_00: It's a remarkable piece of physiological engineering, really.
• 3:17
  SPEAKER_00: But before we get into the,
• 3:18
  SPEAKER_00: you know,
• 3:18
  SPEAKER_00: the molecular weeds of serotonin and cortical thickness,
• 3:22
  SPEAKER_00: I want to understand the historical inertia we're fighting here.
• 3:26
  SPEAKER_01: Oh, the dualism.
• 3:27
  SPEAKER_00: Yeah.
• 3:27
  SPEAKER_00: Medicine has been snubberingly resistant to this bidirectional concept.
• 3:32
  SPEAKER_00: For centuries, we've operated on this rigid dualism.
• 3:36
  SPEAKER_00: We have organic disease.
• 3:38
  SPEAKER_00: Meaning something a pathologist can put under a microscope.
• 3:40
  SPEAKER_01: And then you have functional disease.
• 3:42
  SPEAKER_00: Right.
• 3:42
  SPEAKER_00: Which was historically just the polite,
• 3:44
  SPEAKER_00: chart friendly way of saying a patient was hysterical or making it up.
• 3:49
  SPEAKER_00: Why does this dualistic thinking still permeate the medical wards today?
• 3:53
  SPEAKER_01: Well, dualism persists because it is cognitively easy.
• 3:57
  SPEAKER_00: Easy for the doctor.
• 3:58
  SPEAKER_01: Exactly.
• 3:59
  SPEAKER_01: It absolves the physician of uncertainty.
• 4:01
  SPEAKER_01: The chapter actually traces the roots of our current understanding back to
• 4:04
  SPEAKER_01: the 19th century, specifically to a chap named William Beaumont.
• 4:08
  SPEAKER_00: Right.
• 4:08
  SPEAKER_00: The pioneering physiologist.
• 4:10
  SPEAKER_01: Yes.
• 4:10
  SPEAKER_01: And he had a rather unique opportunity.
• 4:12
  SPEAKER_01: He studied a patient with a permanent gastric fistula.
• 4:15
  SPEAKER_00: A literal window into the stomach.
• 4:17
  SPEAKER_01: Literally.
• 4:18
  SPEAKER_01: Beaumont could physically look inside a living human stomach,
• 4:22
  SPEAKER_01: and he was the first to objectively record how human emotions, anger, fear,
• 4:28
  SPEAKER_01: frustration,
• 4:29
  SPEAKER_01: Directly and instantaneously altered gastric acid secretion and mucosal blood flow.
• 4:34
  SPEAKER_00: He saw it happen.
• 4:35
  SPEAKER_01: In real time, he saw the psyche drive the physiology.
• 4:38
  SPEAKER_00: So we had objective proof in the 1800s that emotions alter gut histology,
• 4:44
  SPEAKER_00: but then we seem to have just collectively forgotten it.
• 4:47
  SPEAKER_01: We did.
• 4:48
  SPEAKER_00: The text uses peptic ulcer disease to highlight this intellectual failure, right?
• 4:53
  SPEAKER_00: Because for decades, ulcers were the poster child for psychosomatic illness.
• 4:57
  SPEAKER_01: Oh, absolutely.
• 4:57
  SPEAKER_01: Yeah.
• 4:58
  SPEAKER_01: The prevailing dogma was
• 4:59
  SPEAKER_01: that high-stress executives basically gave themselves ulcers through sheer anxiety.
• 5:03
  SPEAKER_00: Right, it was functional.
• 5:04
  SPEAKER_00: It was seen as a lifestyle failure.
• 5:05
  SPEAKER_01: Until the biomedical model fought back with the discovery of Helicobacter pylori.
• 5:10
  SPEAKER_00: The bacteria.
• 5:10
  SPEAKER_01: Yeah.
• 5:11
  SPEAKER_01: The identification of a bacterial pathogen completely stripped peptic ulcer disease
• 5:15
  SPEAKER_01: of all its psychiatric connotations.
• 5:17
  SPEAKER_01: It was instantly reclassified as an organic infectious disease.
• 5:20
  SPEAKER_00: You find the bug, you give the antibiotics, you cure the ulcer.
• 5:23
  SPEAKER_01: And the dualists felt entirely vindicated by that.
• 5:27
  SPEAKER_01: But the chapter points out the massive glaring anomaly that
• 5:30
  SPEAKER_01: the biomedical model just completely ignored.
• 5:33
  SPEAKER_00: Which was?
• 5:34
  SPEAKER_01: Eradication of H. pylori did not cure the illness for everyone.
• 5:37
  SPEAKER_00: I want to pause on that because that is vital.
• 5:39
  SPEAKER_00: The structural damage is gone.
• 5:41
  SPEAKER_00: The mucosa is visually and histologically healed.
• 5:44
  SPEAKER_01: The organic box is checked as cured.
• 5:47
  SPEAKER_00: So why is the patient still in debilitating pain?
• 5:50
  SPEAKER_01: Because the initial peripheral insult,
• 5:52
  SPEAKER_01: the infection, permanently altered the central processing of pain.
• 5:56
  SPEAKER_01: The alarm system essentially kept ringing long after the fire was put out.
• 5:59
  SPEAKER_01: Wow.
• 6:00
  SPEAKER_01: Which brings us to George Engle-Ureau's biopsychosocial model published in 1977.
• 6:06
  SPEAKER_01: The text posits that this is really the only logical framework capable
• 6:09
  SPEAKER_01: of encompassing GI disorders.
• 6:11
  SPEAKER_00: Because biological, psychological and social factors aren't competing diagnostic alternatives.
• 6:16
  SPEAKER_01: Right.
• 6:16
  SPEAKER_01: You don't have to decide if a patient's abdominal agony is biological or are psychological.
• 6:22
  SPEAKER_01: They are interacting variables within the exact same neurobiological circuit.
• 6:26
  SPEAKER_00: Okay, let's pull apart the mechanics of that circuit then.
• 6:29
  SPEAKER_00: The mechanisms and models.
• 6:31
  SPEAKER_00: The text outlines that the gut and the brain don't just influence each other from afar.
• 6:35
  SPEAKER_00: They literally speak the same dialect.
• 6:37
  SPEAKER_01: They do.
• 6:38
  SPEAKER_01: The chemical language of this bidirectional communication relies on
• 6:41
  SPEAKER_01: the exact same neurotransmitters.
• 6:44
  SPEAKER_00: The crossover is profound.
• 6:46
  SPEAKER_00: I know the text focuses heavily on serotonin or 5-HT.
• 6:50
  SPEAKER_00: And in a psychiatric context,
• 6:51
  SPEAKER_00: we instinctively associate 5-HT with mood regulation,
• 6:55
  SPEAKER_00: anxiety, and, you know, the mechanism of action for our frontline antidepressants.
• 7:00
  SPEAKER_01: Sure.
• 7:00
  SPEAKER_01: But the overwhelming majority of the body serotonin is actually synthesized
• 7:04
  SPEAKER_01: and stored in the enterochromythin cells of the gastrointestinal tract.
• 7:08
  SPEAKER_00: Down in the gut.
• 7:09
  SPEAKER_01: Exactly.
• 7:10
  SPEAKER_01: Down there,
• 7:11
  SPEAKER_01: serotonin acts as a major signaling molecule for peristalsis,
• 7:14
  SPEAKER_01: for secretion, and for the mediation of visceral sensation.
• 7:17
  SPEAKER_00: And it isn't just isolated to serotonin, is it?
• 7:20
  SPEAKER_01: No, not at all.
• 7:20
  SPEAKER_01: We're looking at a shared vocabulary involving norepinephrine,
• 7:24
  SPEAKER_01: gortecotropin releasing factor, and endogenous opioids.
• 7:28
  SPEAKER_00: And that shared vocabulary completely changes how we view stress
• 7:31
  SPEAKER_00: because stress is no longer just this abstract emotional state, right?
• 7:36
  SPEAKER_00: It's a profound biological event that floods this entire shared system.
• 7:40
  SPEAKER_01: Spot on.
• 7:41
  SPEAKER_01: When an individual experiences an extraceptive threat,
• 7:44
  SPEAKER_01: say severe financial ruin or a traumatic bereavement,
• 7:48
  SPEAKER_01: or even an interoceptive threat like a severe bout of gastroenteritis,
• 7:52
  SPEAKER_01: the biological response is identical.
• 7:54
  SPEAKER_00: The body doesn't differentiate.
• 7:55
  SPEAKER_01: It doesn't.
• 7:56
  SPEAKER_01: The HPA axis activates.
• 7:58
  SPEAKER_01: Corticotropin releasing factor, or CRF, is secreted.
• 8:02
  SPEAKER_00: And what does that do in the gut?
• 8:03
  SPEAKER_01: In the gut, this cascade directly alters motility, usually accelerating it.
• 8:08
  SPEAKER_01: It increases mucosal permeability, which is often colloquially called a leaky gut.
• 8:12
  SPEAKER_00: Which sounds terrifying.
• 8:13
  SPEAKER_01: It's not great.
• 8:14
  SPEAKER_01: It allows bacterial antigens to cross the epithelial barrier.
• 8:18
  SPEAKER_01: And most critically for our discussion today,
• 8:20
  SPEAKER_01: this stress cascade actively lowers the pain threshold of the sensory nerves in
• 8:24
  SPEAKER_01: the gut wall.
• 8:25
  SPEAKER_00: Okay, let's use an analogy to ground this concept of visceral hypersensitivity.
• 8:29
  SPEAKER_01: Go for it.
• 8:29
  SPEAKER_00: Think of the peripheral and central nervous systems as a highly complex soundboard
• 8:34
  SPEAKER_00: in a recording studio.
• 8:35
  SPEAKER_01: Okay.
• 8:35
  SPEAKER_00: In a healthy physiological state,
• 8:38
  SPEAKER_00: the signals originating from the gut The sounds of normal peristalsis,
• 8:42
  SPEAKER_00: digestion, gas distension.
• 8:44
  SPEAKER_00: They're mixed at an incredibly low volume.
• 8:46
  SPEAKER_01: The brain just filters them out completely.
• 8:48
  SPEAKER_01: You're entirely unaware of your lunch digesting.
• 8:51
  SPEAKER_00: Right.
• 8:51
  SPEAKER_00: But in the disorders we are discussing today,
• 8:54
  SPEAKER_00: it is as if the volume fader for visceral sensation has been violently pushed to
• 8:59
  SPEAKER_00: the maximum and the knob snapped off.
• 9:01
  SPEAKER_01: I love that analogy.
• 9:02
  SPEAKER_00: Suddenly,
• 9:03
  SPEAKER_00: the entirely normal acoustic baseline of digestion sounds to the brain like
• 9:07
  SPEAKER_00: a deafening, overwhelming siren.
• 9:09
  SPEAKER_01: The soundboard analogy perfectly captures peripheral visceral hypersensitivity.
• 9:14
  SPEAKER_01: You know, the aberrant nerves themselves are hyper excitable.
• 9:17
  SPEAKER_01: But the chapter pushes us to look even deeper at central sensitization.
• 9:21
  SPEAKER_00: Which means the problems in the brain itself.
• 9:23
  SPEAKER_01: Exactly.
• 9:24
  SPEAKER_01: The issue is not merely that the gut is generating a louder signal.
• 9:28
  SPEAKER_01: The actual hardware of the brain reorganizes itself to become dangerously efficient
• 9:33
  SPEAKER_01: at receiving that signal.
• 9:34
  SPEAKER_00: Wait, it reorganizes itself?
• 9:36
  SPEAKER_01: Yes.
• 9:37
  SPEAKER_01: We are looking at functional neuroimaging data
• 9:40
  SPEAKER_01: that demonstrates quantifiable structural changes in the brains of patients
• 9:44
  SPEAKER_01: with chronic functional GI disorders.
• 9:47
  SPEAKER_00: I'm struggling to accept the evolutionary logic of that, to be fair.
• 9:51
  SPEAKER_00: Why would the brain dedicate more resources to feeling stomach pain?
• 9:54
  SPEAKER_00: If there's no structural lesion in the gut,
• 9:57
  SPEAKER_00: why are we seeing increased cortical thickness in the somatosensory cortex?
• 10:01
  SPEAKER_01: Well, it's a maladaptive neuroplastic response.
• 10:04
  SPEAKER_01: The somatosensory cortex is the region responsible for mapping sensory input, right?
• 10:08
  SPEAKER_00: Yeah.
• 10:09
  SPEAKER_01: When it is just bombarded with constant amplified signals from
• 10:12
  SPEAKER_01: the hyperexcitable gut, it structurally hypertrophies.
• 10:16
  SPEAKER_01: It builds more receivers.
• 10:18
  SPEAKER_01: It sickens.
• 10:18
  SPEAKER_01: Yes.
• 10:19
  SPEAKER_01: But the more insidious change happens in the regions responsible for pain processing
• 10:23
  SPEAKER_01: and emotional regulation.
• 10:24
  SPEAKER_00: The functional MRI data shows a decrease in gray matter, right?
• 10:27
  SPEAKER_01: Yes.
• 10:28
  SPEAKER_01: Actual cortical thinning in the insula and the anterior cingulate cortex.
• 10:32
  SPEAKER_00: So the areas of the brain that would normally contextualize the pain,
• 10:36
  SPEAKER_00: the areas that would apply a top-down inhibitory break and say,
• 10:39
  SPEAKER_00: hey, this is just normal digestion, ignore it.
• 10:41
  SPEAKER_00: Those areas are physically atrophying.
• 10:44
  SPEAKER_01: Precisely.
• 10:44
  SPEAKER_01: The brain is literally losing its structural capacity to inhibit the pain signal.
• 10:49
  SPEAKER_00: What on earth triggers that profound structural remodeling?
• 10:53
  SPEAKER_00: The chapter points a massive finger at early life trauma, doesn't it?
• 10:56
  SPEAKER_01: It does.
• 10:57
  SPEAKER_01: And this is where the social and psychological pillars of
• 11:00
  SPEAKER_01: the biopsychosocial model anchor firmly into the biology.
• 11:04
  SPEAKER_01: Animal models clearly demonstrate that adverse early life events,
• 11:08
  SPEAKER_01: such as maternal separation protocols in rodents,
• 11:11
  SPEAKER_01: permanently alter the developmental trajectory of the HPA axis.
• 11:15
  SPEAKER_00: So the stress system is fundamentally changed from the start.
• 11:17
  SPEAKER_01: Exactly.
• 11:18
  SPEAKER_01: These animals grow into adult rodents with profound visceral hypersensitivity
• 11:21
  SPEAKER_01: and altered stress responses.
• 11:23
  SPEAKER_00: And when we translate that to the clinical data in humans, what are we seeing?
• 11:27
  SPEAKER_01: We see a devastating correlation.
• 11:29
  SPEAKER_01: A history of severe psychosocial trauma,
• 11:32
  SPEAKER_01: particularly childhood sexual or physical abuse,
• 11:36
  SPEAKER_01: acts as an independent risk factor for the development
• 11:38
  SPEAKER_01: of severe refractory functional GI disorders decades later.
• 11:43
  SPEAKER_00: Decades later.
• 11:44
  SPEAKER_00: That's incredible.
• 11:44
  SPEAKER_01: Because the trauma occurs while the nervous system is still highly plastic.
• 11:49
  SPEAKER_01: It essentially hardwires the autonomic nervous system to exist in a state
• 11:53
  SPEAKER_01: of chronic hyperarousal.
• 11:55
  SPEAKER_01: The system is programmed from childhood to interpret benign visceral sensations
• 12:00
  SPEAKER_01: as catastrophic threats.
• 12:01
  SPEAKER_00: Okay, we've established the invisible architecture here.
• 12:04
  SPEAKER_00: We have the bidirectional loop.
• 12:06
  SPEAKER_00: The shared neurotransmitters,
• 12:08
  SPEAKER_00: the structural brain atrophy of central sensitization,
• 12:11
  SPEAKER_00: and the epigenetic shadow of early trauma.
• 12:13
  SPEAKER_01: It's a lot.
• 12:14
  SPEAKER_00: It is.
• 12:14
  SPEAKER_00: Now I want to walk onto the wards.
• 12:15
  SPEAKER_00: I want to see how this neurobiology actually manifests clinically.
• 12:18
  SPEAKER_01: Let's do it.
• 12:19
  SPEAKER_00: The chapter explores a really broad spectrum,
• 12:21
  SPEAKER_00: beginning with conditions defined by severe,
• 12:23
  SPEAKER_00: visible organic inflammation, inflammatory bowel disease.
• 12:27
  SPEAKER_01: Yes.
• 12:28
  SPEAKER_01: Inflammatory bowel disease, or IBD,
• 12:30
  SPEAKER_01: serves as the ultimate proof of concept for the brain-gut axis because
• 12:34
  SPEAKER_01: the peripheral pathology is undeniable.
• 12:36
  SPEAKER_00: We're primarily discussing Crohn disease, right?
• 12:38
  SPEAKER_01: Crohn disease,
• 12:39
  SPEAKER_01: which can cause transmural inflammation anywhere from the oral cavity down to
• 12:43
  SPEAKER_01: the periannal region,
• 12:44
  SPEAKER_01: and ulcerative colitis, which causes mucosal inflammation restricted to the colon.
• 12:49
  SPEAKER_00: And the etiology involves an exaggerated,
• 12:51
  SPEAKER_00: inappropriate immunologic response to the gut microbiome in
• 12:55
  SPEAKER_00: a genetically susceptible host.
• 12:57
  SPEAKER_01: That's the core of it, yes.
• 12:59
  SPEAKER_00: The physical symptoms are just brutal.
• 13:01
  SPEAKER_00: Severe abdominal pain, profound bloody diarrhea, malabsorption, and significant weight loss.
• 13:07
  SPEAKER_00: But, you know, reading the chapter, the psychiatric morbidity is what really stands out to me.
• 13:11
  SPEAKER_01: It's massive.
• 13:12
  SPEAKER_01: Up to one-third of patients with IBD have a co-occurring mood disorder.
• 13:16
  SPEAKER_00: And the traditional linear assumption would be that,
• 13:18
  SPEAKER_00: well, having a chronic, painful, socially embarrassing disease makes you depressed.
• 13:24
  SPEAKER_00: A purely reactive depression.
• 13:25
  SPEAKER_01: Right, which sounds logical.
• 13:26
  SPEAKER_00: But the data refuses to support that linear model, doesn't it?
• 13:29
  SPEAKER_01: Completely refuses.
• 13:31
  SPEAKER_01: The relationship is fiercely bi-directional.
• 13:33
  SPEAKER_01: The text cites an enormous cohort study involving over 403,000 participants.
• 13:39
  SPEAKER_00: Over 400,000.
• 13:41
  SPEAKER_00: The statistical power of a study that size is immense.
• 13:44
  SPEAKER_01: It really is.
• 13:45
  SPEAKER_01: And it demonstrated that a pre-existing diagnosis of depression acts as
• 13:49
  SPEAKER_01: an independent risk factor for the subsequent development of Crohn's disease
• 13:52
  SPEAKER_01: or ulcerative colitis.
• 13:53
  SPEAKER_00: The psychiatric state actually preceded the inflammatory autoimmune cascade.
• 13:58
  SPEAKER_01: Yes, which absolutely shatters the reactive depression model.
• 14:02
  SPEAKER_00: It really does.
• 14:03
  SPEAKER_01: And once the IBD is established, the psychological state directly dictates the disease course.
• 14:08
  SPEAKER_01: During periods of active disease relapse,
• 14:10
  SPEAKER_01: when the systemic inflammatory burden is highest,
• 14:13
  SPEAKER_01: the prevalence of major depression and severe anxiety just skyrockets.
• 14:17
  SPEAKER_00: I want to look at this from the perspective of the liaison psychiatrist.
• 14:20
  SPEAKER_00: When you are called to consult on a patient with an acute IBD flare,
• 14:24
  SPEAKER_00: what are the specific psychological landmines you are looking for?
• 14:27
  SPEAKER_00: Because, I mean, it's not just a low mood.
• 14:29
  SPEAKER_00: It is a highly specific disease-related trauma.
• 14:33
  SPEAKER_01: Absolutely.
• 14:33
  SPEAKER_01: You're looking at a patient whose entire world has essentially shrunk to
• 14:37
  SPEAKER_01: the distance between them and the nearest toilet.
• 14:40
  SPEAKER_00: Right.
• 14:40
  SPEAKER_01: Fecal incontinence is a profound source of shame and can rapidly precipitate severe agoraphobia.
• 14:46
  SPEAKER_01: You see patients with medical trauma or PTSD stemming from recurrent,
• 14:51
  SPEAKER_01: painful,
• 14:51
  SPEAKER_01: invasive procedures or major abdominal surgeries like bowel resections
• 14:56
  SPEAKER_01: or ostomy placements.
• 14:58
  SPEAKER_00: The psychological toll is huge.
• 15:00
  SPEAKER_01: It is.
• 15:00
  SPEAKER_01: Furthermore,
• 15:01
  SPEAKER_01: the massive systemic release of pro-inflammatory cytokines during
• 15:05
  SPEAKER_01: a flare actually crosses the blood-brain barrier
• 15:08
  SPEAKER_01: and directly induces what we call sickness behavior lethargy and hedonia
• 15:12
  SPEAKER_01: and measurable cognitive dysfunction,
• 15:14
  SPEAKER_01: particularly deficits in processing speed and executive function.
• 15:17
  SPEAKER_00: But the psychiatrist on the medical ward isn't just managing
• 15:20
  SPEAKER_00: the psychological fallout of the disease, are they?
• 15:22
  SPEAKER_01: No, unfortunately not.
• 15:23
  SPEAKER_00: They have to manage the psychological fallout of the gastroenterologist's treatment plan.
• 15:28
  SPEAKER_00: The chapter provides a really striking clinical case that highlights
• 15:31
  SPEAKER_00: the inherent danger of treating the gut without considering the brain.
• 15:34
  SPEAKER_01: Ah, yes.
• 15:35
  SPEAKER_01: The 62-year-old woman.
• 15:37
  SPEAKER_01: Right.
• 15:37
  SPEAKER_00: We have a 62-year-old woman with a known history of ulcerative colitis.
• 15:41
  SPEAKER_01: The clinical presentation is an acute severe exacerbation.
• 15:44
  SPEAKER_01: She presents with a two-week history of worsening rectal bleeding,
• 15:48
  SPEAKER_01: significant abdominal cramping, and high-frequency diarrhea.
• 15:52
  SPEAKER_00: So she's admitted to the medical ward.
• 15:54
  SPEAKER_01: She is.
• 15:54
  SPEAKER_01: The gastroenterology team performs a flexible sigmoidoscopy which reveals
• 15:58
  SPEAKER_01: a highly friable ulcerated mucosa.
• 16:01
  SPEAKER_01: The inflammatory burden is massive.
• 16:04
  SPEAKER_00: So the medical team responds appropriately based on their algorithm.
• 16:07
  SPEAKER_00: They initiate high-dose intravenous corticosteroids,
• 16:10
  SPEAKER_00: specifically hydrocortisone, at 100 milligrams daily.
• 16:14
  SPEAKER_01: Standard protocol.
• 16:15
  SPEAKER_00: And from a strictly gastrointestinal perspective, the intervention is a triumph.
• 16:19
  SPEAKER_00: Within 48 hours, her bowel frequency decreases and the bleeding stops.
• 16:23
  SPEAKER_01: But on day three, the clinical picture derails completely.
• 16:26
  SPEAKER_00: Her mental state fractures.
• 16:28
  SPEAKER_01: It does.
• 16:28
  SPEAKER_01: The ward nurses report that she has become acutely confused,
• 16:31
  SPEAKER_01: severely agitated, and is pacing the ward.
• 16:34
  SPEAKER_00: The medical team initially suspects an infectious delirium or
• 16:38
  SPEAKER_00: a metabolic derangement,
• 16:39
  SPEAKER_00: which, you know, is entirely appropriate clinical reasoning.
• 16:42
  SPEAKER_01: Absolutely appropriate.
• 16:43
  SPEAKER_01: However, her blood cultures, inflammatory markers, and a CT scan of her head all return normal.
• 16:50
  SPEAKER_01: By day six,
• 16:50
  SPEAKER_01: she's experiencing intense paranoid delusions,
• 16:53
  SPEAKER_01: convinced that the nursing staff are undercover agents attempting to poison her.
• 16:57
  SPEAKER_00: So the liaison psychiatrist is consulted.
• 17:00
  SPEAKER_00: Now, looking at this through the lens of the great gut-brain exchange,
• 17:04
  SPEAKER_00: how do we formulate this rapid cognitive collapse?
• 17:07
  SPEAKER_01: The formulation rests entirely on recognizing iatrogenic harm.
• 17:12
  SPEAKER_01: The diagnosis is corticosteroid-induced psychosis.
• 17:15
  SPEAKER_00: It's the treatment itself.
• 17:16
  SPEAKER_01: Yes.
• 17:17
  SPEAKER_01: Corticosteroids are powerful modulators of the central nervous system.
• 17:20
  SPEAKER_01: They readily cross the blood-brain barrier and bind to glucocorticoid receptors,
• 17:25
  SPEAKER_01: which are densely packed in the hippocampus and the amygdala areas that are critical
• 17:29
  SPEAKER_01: for memory, emotion, and threat detection.
• 17:31
  SPEAKER_00: And high doses overload that system.
• 17:33
  SPEAKER_01: Exactly.
• 17:34
  SPEAKER_01: High doses can severely dysregulate dopaminergic transmission,
• 17:38
  SPEAKER_01: precipitating an acute psychotic episode.
• 17:40
  SPEAKER_01: While the risk is relatively low,
• 17:42
  SPEAKER_01: it is a well-documented phenomenon,
• 17:44
  SPEAKER_01: particularly in females on high-dose IV regimens.
• 17:47
  SPEAKER_00: But the intervention here requires a really delicate negotiation between psychiatry
• 17:51
  SPEAKER_00: and gastroenterology, right?
• 17:53
  SPEAKER_00: Because you can't just stop the steroid's cold turkey, or her colon might perforate.
• 17:57
  SPEAKER_01: No, you definitely can't.
• 17:59
  SPEAKER_00: But you also can't leave her actively psychotic on the ward.
• 18:03
  SPEAKER_01: The management demands rapid coordination.
• 18:05
  SPEAKER_01: The intravenous hydrocortisone must be aggressively tapered and discontinued,
• 18:10
  SPEAKER_01: transitioning her IBD management to an alternative immunosuppressive agent,
• 18:14
  SPEAKER_01: such as azathioprine.
• 18:16
  SPEAKER_00: Okay, and for the psychosis?
• 18:18
  SPEAKER_01: To manage the acute psychosis and behavioral disturbance safely,
• 18:21
  SPEAKER_01: she has commenced on a low dose of an antipsychotic, specifically haloperidol.
• 18:27
  SPEAKER_00: And the outcome?
• 18:27
  SPEAKER_01: Within 10 days of tapering the steroid and initiating the antipsychotic,
• 18:32
  SPEAKER_01: Her delusions resolve entirely and her baseline cognition returns.
• 18:35
  SPEAKER_00: It is a stark reminder that when we aggressively manipulate the immune gut axis
• 18:40
  SPEAKER_00: with exogenous hormones, the brain is highly vulnerable collateral damage.
• 18:45
  SPEAKER_01: Couldn't have said it better.
• 18:46
  SPEAKER_00: Okay,
• 18:46
  SPEAKER_00: so we've examined the organic end of the spectrum where the inflammation is visible
• 18:49
  SPEAKER_00: and undeniable, but the chapter forces us into much murkier waters now.
• 18:54
  SPEAKER_01: The functional disorders.
• 18:55
  SPEAKER_00: Yeah, we are moving away from IBD and into the realm of functional bowel disorders,
• 19:00
  SPEAKER_00: specifically irritable bowel syndrome, or IBS.
• 19:04
  SPEAKER_00: Here the endoscopies are pristine.
• 19:06
  SPEAKER_00: The biopsies show healthy tissue, yet the patient is completely debilitated.
• 19:10
  SPEAKER_01: And the sheer scale of this problem is staggering.
• 19:13
  SPEAKER_01: IBS affects over 10% of the global adult population.
• 19:18
  SPEAKER_00: 10%, that is massive.
• 19:20
  SPEAKER_01: The socioeconomic burden,
• 19:22
  SPEAKER_01: the loss of productivity, and the drain on healthcare resources are just immense.
• 19:26
  SPEAKER_01: IDS represents the prototypical disorder of gut-brain interaction.
• 19:30
  SPEAKER_01: It is defined by recurrent abdominal pain linked to alterations in bowel habits.
• 19:34
  SPEAKER_00: Because there's no structural biomarker, right?
• 19:36
  SPEAKER_00: So diagnosis relies on clinical pattern recognition.
• 19:38
  SPEAKER_01: Exactly.
• 19:39
  SPEAKER_01: Via the Rome 4V criteria.
• 19:41
  SPEAKER_00: Let's break down those criteria because they tell a very specific physiological story.
• 19:45
  SPEAKER_00: The Rome IV V criteria require recurrent abdominal pain occurring at least one day
• 19:50
  SPEAKER_00: a week for the last three months.
• 19:51
  SPEAKER_01: But the pain must be associated with two or more specific features.
• 19:55
  SPEAKER_00: Right.
• 19:55
  SPEAKER_00: It has to be related to defecation associated with a change in the frequency
• 20:00
  SPEAKER_00: of stool or associated with a change in the form of the stool.
• 20:03
  SPEAKER_01: The critical insight here is the temporal locking of the symptoms.
• 20:07
  SPEAKER_01: The pain is not random.
• 20:08
  SPEAKER_01: It fluctuates in lockstep with the mechanical and physiological actions of the lower GI tract.
• 20:13
  SPEAKER_00: Which distinguishes it from continuous pain syndromes.
• 20:16
  SPEAKER_01: Yes.
• 20:16
  SPEAKER_01: IBS is further subtyped based on the predominant bowel habit.
• 20:20
  SPEAKER_01: IBSC for constipation, IBSD for diarrhea, and IBSM for a mixed presentation.
• 20:26
  SPEAKER_00: But the psychiatric comorbidity is the real focus of the chapter here.
• 20:29
  SPEAKER_00: We're not talking about a mild reactive frustration.
• 20:32
  SPEAKER_00: Over 50% of patients seeking care for IBS meet the criteria for a formal psychiatric diagnosis.
• 20:39
  SPEAKER_01: Major depressive disorder, panic disorder, generalized anxiety disorder, PTSD.
• 20:43
  SPEAKER_01: It's a huge overlap.
• 20:45
  SPEAKER_00: And, returning to our earlier discussion, the temporal relationship is fascinating.
• 20:50
  SPEAKER_00: A massive prospective study of nearly 4,000 IBS patients revealed
• 20:54
  SPEAKER_00: a 3.6-fold increased risk of developing new-onset psychiatric disorders compared
• 20:59
  SPEAKER_00: to healthy controls.
• 21:00
  SPEAKER_01: Furthermore,
• 21:01
  SPEAKER_01: if a patient experiences a standard acute bout of infectious gastroenteritis,
• 21:06
  SPEAKER_01: their baseline psychological state,
• 21:08
  SPEAKER_01: their levels of chronic stress,
• 21:10
  SPEAKER_01: their tendency to catastrophize is a powerful independent predictor of
• 21:15
  SPEAKER_01: whether they will fully recover or go on to develop post-infectious IBS.
• 21:19
  SPEAKER_00: Let's ground this in the second clinical case from the text,
• 21:22
  SPEAKER_00: which I think brilliantly illustrates
• 21:24
  SPEAKER_00: the psychological camouflage these patients often use.
• 21:27
  SPEAKER_01: Ah, the television producer.
• 21:29
  SPEAKER_00: Right.
• 21:29
  SPEAKER_00: We have a 35-year-old female television producer.
• 21:32
  SPEAKER_00: She presents to gastroenterology with a three-year history
• 21:36
  SPEAKER_00: of worsening abdominal pain, severe bloating, and an alternating bowel habit.
• 21:41
  SPEAKER_01: And the pain is excruciating.
• 21:43
  SPEAKER_01: She rates it an 8 out of 10.
• 21:44
  SPEAKER_01: It's destroying her career and her marriage.
• 21:47
  SPEAKER_00: The key to this case is her rigid presentation bias.
• 21:50
  SPEAKER_00: During the initial medical workup, she flatly denies any psychiatric history.
• 21:53
  SPEAKER_01: She denies feeling low.
• 21:54
  SPEAKER_01: She denies anxiety.
• 21:56
  SPEAKER_00: She insists,
• 21:57
  SPEAKER_00: with intense conviction,
• 21:58
  SPEAKER_00: that her problem is purely a physical malfunction of her bowel.
• 22:01
  SPEAKER_01: So the gastroenterologist performs an exhaustive workup.
• 22:05
  SPEAKER_01: Bloods, coliac serology,
• 22:07
  SPEAKER_01: fecal calprotectin, and a lower GI endoscopy are all completely unremarkable.
• 22:12
  SPEAKER_00: Though it is worth noting that she found the endoscopy intolerably painful,
• 22:17
  SPEAKER_00: requiring extra sedation, which,
• 22:19
  SPEAKER_00: based on what we talked about,
• 22:20
  SPEAKER_00: is a massive red flag for the visceral hypersensitivity we discussed earlier.
• 22:24
  SPEAKER_01: Precisely.
• 22:26
  SPEAKER_01: It is clinical evidence of the broken volume knob.
• 22:28
  SPEAKER_01: Her sensory nerves are literally screaming.
• 22:31
  SPEAKER_00: Right.
• 22:32
  SPEAKER_00: So the gastroenterologist trials antispasmonics, dietary modifications, and neuromodulators.
• 22:37
  SPEAKER_00: Nothing works.
• 22:38
  SPEAKER_00: Out of options, the gastroenterologist refers her to liaison psychiatry.
• 22:42
  SPEAKER_01: And she is furious.
• 22:44
  SPEAKER_01: Of course
• 22:44
  SPEAKER_00: she is.
• 22:45
  SPEAKER_00: She feels dismissed.
• 22:46
  SPEAKER_00: In her mind,
• 22:46
  SPEAKER_00: the psychiatric referral translates to the doctor thinks I'm crazy and
• 22:50
  SPEAKER_00: the pain is fake.
• 22:51
  SPEAKER_01: Exactly.
• 22:51
  SPEAKER_00: How does the psychiatrist bypass that defensive wall?
• 22:54
  SPEAKER_00: Because if you launch straight into questions about her childhood or her mood,
• 22:58
  SPEAKER_00: she's going to walk out of the clinic.
• 22:59
  SPEAKER_01: The psychiatrist in this scenario relies on advanced communication skills
• 23:03
  SPEAKER_01: to dismantle the dualistic threat.
• 23:05
  SPEAKER_01: The initial intervention is purely validating.
• 23:08
  SPEAKER_00: Validating the physical symptoms.
• 23:09
  SPEAKER_01: Yes.
• 23:10
  SPEAKER_01: The psychiatrist does not challenge her physical symptoms.
• 23:12
  SPEAKER_01: They center them.
• 23:13
  SPEAKER_01: They state unequivocally, I believe your pain is an 8 out of 10.
• 23:17
  SPEAKER_01: I'm here to help you manage the severe physical distress.
• 23:20
  SPEAKER_00: It is the ultimate de-escalation technique.
• 23:23
  SPEAKER_01: It creates psychological safety.
• 23:25
  SPEAKER_01: By validating the physical reality of the pain,
• 23:27
  SPEAKER_01: the patient no longer feels the need to aggressively defend it.
• 23:31
  SPEAKER_00: And once that defensive posture relaxed, the clinical picture expanded dramatically, right?
• 23:36
  SPEAKER_01: It did.
• 23:36
  SPEAKER_01: She eventually disclosed profound fatigue,
• 23:39
  SPEAKER_01: middle insomnia, significant weight loss, and anhedonia.
• 23:43
  SPEAKER_00: And the psychosocial stressors.
• 23:45
  SPEAKER_01: She revealed an intensely toxic work environment in television production,
• 23:49
  SPEAKER_01: severe marital discord, and a lifelong crippling struggle with perfectionism.
• 23:53
  SPEAKER_00: The perfectionism is a crucial detail.
• 23:55
  SPEAKER_00: It acts as a chronic psychological stressor,
• 23:58
  SPEAKER_00: a constant hum of perceived failure that keeps the HPA axis perpetually engaged,
• 24:02
  SPEAKER_00: flooding the gut with CRF and maintaining the visceral hypersensitivity.
• 24:07
  SPEAKER_01: Spot on.
• 24:07
  SPEAKER_01: By addressing the physical pain first,
• 24:09
  SPEAKER_01: the psychiatrist gained access to the psychological engine that was actually driving
• 24:13
  SPEAKER_01: the illness.
• 24:14
  SPEAKER_00: And that formulation completely changes the treatment trajectory, doesn't it?
• 24:17
  SPEAKER_00: From a futile search for a bowel pathology to a targeted intervention
• 24:22
  SPEAKER_00: on central stress processing.
• 24:23
  SPEAKER_01: Completely.
• 24:24
  SPEAKER_00: But the chapter doesn't stop at IBS.
• 24:26
  SPEAKER_00: It moves to a condition that sounds infinitely more challenging,
• 24:30
  SPEAKER_00: centrally mediated abdominal pain syndrome or CEPS.
• 24:34
  SPEAKER_01: CEPS is tough.
• 24:35
  SPEAKER_00: If IBS is the brain overreacting to normal gut functions,
• 24:39
  SPEAKER_00: CAKS is what happens when the gut is completely silent.
• 24:42
  SPEAKER_00: But the brain is generating continuous pain all on its own.
• 24:46
  SPEAKER_01: The Rome, though, criteria for CAPS paint a pretty grim clinical picture.
• 24:51
  SPEAKER_01: The pain must be continuous or nearly continuous.
• 24:54
  SPEAKER_00: And crucially,
• 24:54
  SPEAKER_00: unlike IBS, it has no physiological relationship to eating, defecation, or menses.
• 24:59
  SPEAKER_01: Right.
• 25:00
  SPEAKER_01: It must severely limit daily functioning,
• 25:02
  SPEAKER_01: and it cannot be explained by any other structural or psychiatric condition.
• 25:06
  SPEAKER_01: It is a pure failure of central pain modulation.
• 25:09
  SPEAKER_00: The clinical case for CFES is arguably the most tragic in the chapter.
• 25:13
  SPEAKER_00: It highlights the phenomenon of the disenfranchised patient.
• 25:16
  SPEAKER_00: We have a 19-year-old woman.
• 25:18
  SPEAKER_01: She has chronic, burning, unremitting abdominal pain that began in early adolescence.
• 25:23
  SPEAKER_00: She also carries a diagnosis of fibromyalgia,
• 25:25
  SPEAKER_00: which tells us her central sensitization is widespread,
• 25:28
  SPEAKER_00: affecting somatic pathways as well as visceral ones.
• 25:31
  SPEAKER_01: The staggering data point in her history is her healthcare utilization.
• 25:35
  SPEAKER_01: She has had over 30 emergency hospital admissions in a single year.
• 25:40
  SPEAKER_00: 30?
• 25:41
  SPEAKER_01: Yes.
• 25:42
  SPEAKER_01: She has consulted five different consultant gastroenterologists.
• 25:46
  SPEAKER_01: She's been subjected to endless metabolic panels,
• 25:48
  SPEAKER_01: immunology screens, ultrasounds, CT scans, and multiple endoscopies.
• 25:53
  SPEAKER_00: And every single result.
• 25:55
  SPEAKER_01: Unequivocally normal.
• 25:56
  SPEAKER_00: Why does the medical system keep scanning her if the previous 20 scans were normal?
• 26:00
  SPEAKER_00: It seems like madness.
• 26:01
  SPEAKER_01: It's a shared pathology, really, between the doctor and the patient.
• 26:04
  SPEAKER_01: The patient presents in severe distress.
• 26:07
  SPEAKER_01: The physician, trained to find a structural cause, feels immense pressure to intervene.
• 26:11
  SPEAKER_00: They want to fix it.
• 26:12
  SPEAKER_01: They do.
• 26:13
  SPEAKER_01: They order a scan, hoping to find an organic target.
• 26:17
  SPEAKER_01: The patient waits for the result,
• 26:18
  SPEAKER_01: placing all their hope on a definitive diagnosis and a surgical cure.
• 26:22
  SPEAKER_00: And when the scan is normal?
• 26:24
  SPEAKER_01: The physician is relieved, but the patient is devastated.
• 26:27
  SPEAKER_01: The pain is still an 8 out of 10, but now they have no explanation.
• 26:31
  SPEAKER_00: And the chapter argues that these negative investigations actually cause iatrogenic harm.
• 26:36
  SPEAKER_00: They heighten the patient's anxiety, which further amplifies the central sensitization.
• 26:41
  SPEAKER_01: Exactly.
• 26:42
  SPEAKER_01: They become hypervigilant,
• 26:43
  SPEAKER_01: scanning their body for new symptoms,
• 26:45
  SPEAKER_01: leading to more presentations,
• 26:47
  SPEAKER_01: more scans,
• 26:47
  SPEAKER_01: and eventual referral to yet another specialist,
• 26:50
  SPEAKER_01: the cycle of the disenfranchised patient.
• 26:53
  SPEAKER_00: So what's the intervention?
• 26:54
  SPEAKER_01: The clinical intervention for CIPS is not pharmacological or surgical.
• 26:58
  SPEAKER_01: It is philosophical.
• 26:59
  SPEAKER_01: The psychiatrist must collaborate with the primary physician to completely halt
• 27:03
  SPEAKER_01: the cycle of investigation.
• 27:05
  SPEAKER_00: You just stop scanning them.
• 27:06
  SPEAKER_01: You have to.
• 27:07
  SPEAKER_01: The clinical goal must aggressively shift from the exhaustive identification of
• 27:11
  SPEAKER_01: a peripheral cure to adaptation, symptom management and restoration of function.
• 27:17
  SPEAKER_01: We have to stop looking for a broken part in the gut and start treating
• 27:21
  SPEAKER_01: the broken alarm system in the brain.
• 27:23
  SPEAKER_00: Wow.
• 27:23
  SPEAKER_00: Okay, there is one final functional disorder in the chapter,
• 27:26
  SPEAKER_00: and it moves us out of the abdomen and into the thorax.
• 27:28
  SPEAKER_00: Functional chest pain, or FCP.
• 27:31
  SPEAKER_01: Yes, FCP.
• 27:32
  SPEAKER_00: This is defined as recurrent,
• 27:34
  SPEAKER_00: unexplained,
• 27:34
  SPEAKER_00: retrosternal chest pain that persists after cardiac
• 27:38
  SPEAKER_00: and esophageal pathologies have been ruled out.
• 27:40
  SPEAKER_00: And it is incredibly prevalent.
• 27:42
  SPEAKER_01: It accounts for roughly one-third of all patients presenting with non-cardiac chest pain.
• 27:46
  SPEAKER_01: The pathophysiology mirrors what we have discussed,
• 27:49
  SPEAKER_01: heightened esophageal hypersensitivity and altered central processing.
• 27:52
  SPEAKER_00: But the psychological overlay is distinct here.
• 27:54
  SPEAKER_00: Up to 61% of these patients have significant psychiatric comorbidity,
• 27:58
  SPEAKER_00: particularly panic disorder and health anxiety.
• 28:01
  SPEAKER_01: Which is entirely logical.
• 28:03
  SPEAKER_01: If you feel a twinge in your large intestine, you might worry about your lunch.
• 28:06
  SPEAKER_01: If you feel a crushing pain behind your sternum,
• 28:09
  SPEAKER_01: your brain immediately screams, I am having a heart attack and I am going to die.
• 28:13
  SPEAKER_00: The interceptive hypervigilance is extreme.
• 28:17
  SPEAKER_00: The clinical case provided involves a 47-year-old man,
• 28:20
  SPEAKER_00: and his history includes a massive complicating factor.
• 28:23
  SPEAKER_00: He actually had a major heart attack and coronary bypass surgery 17 years ago.
• 28:28
  SPEAKER_01: The prior trauma of a myocardial infarction creates a profound psychological anchor.
• 28:34
  SPEAKER_01: Whenever he feels even minor esophageal distension or a slight change
• 28:38
  SPEAKER_01: in autonomic tone,
• 28:39
  SPEAKER_01: his brain pattern matches it to the trauma of the M.I.,
• 28:42
  SPEAKER_00: He presents to the emergency department repeatedly with severe central chest pain.
• 28:46
  SPEAKER_01: The cardiology workup is flawless.
• 28:48
  SPEAKER_01: Do an angiogram, no recurring ischemia.
• 28:50
  SPEAKER_01: They clear his heart.
• 28:51
  SPEAKER_00: Then gastroenterology takes over.
• 28:53
  SPEAKER_00: Endoscopy, barium meal, 24-hour pH monitoring for acid reflux.
• 28:57
  SPEAKER_00: It's off vigil manometry to check for motor disorders.
• 29:00
  SPEAKER_00: Everything is completely normal.
• 29:01
  SPEAKER_01: Even a high-dose trial of proton pump inhibitors fails to dent the pain.
• 29:05
  SPEAKER_00: He endures 15 months of relentless, terrifying cardiac and GI investigations.
• 29:11
  SPEAKER_01: Finally, out of sheer diagnostic exhaustion, he's referred to a psychiatrist.
• 29:15
  SPEAKER_00: And the psychiatric assessment rapidly uncovers a man suffering
• 29:19
  SPEAKER_00: from severe major depressive disorder and frequent panic attacks.
• 29:22
  SPEAKER_01: The chest pain was the somatic manifestation of severe panic.
• 29:26
  SPEAKER_00: The psychiatrist consults with cardiology,
• 29:28
  SPEAKER_00: ensures there are no contraindications, and starts him on an SSRI.
• 29:33
  SPEAKER_00: Within four to five weeks, his 15-month ordeal of impractible chest pain practically vanishes.
• 29:38
  SPEAKER_01: It's an incredible turnaround.
• 29:40
  SPEAKER_00: Which is a perfect segue into our next major section.
• 29:43
  SPEAKER_00: Integration and clinical reasoning.
• 29:45
  SPEAKER_00: How does a psychiatrist successfully intervene in a system where
• 29:48
  SPEAKER_00: the patient is violently opposed to the idea that their brain is involved?
• 29:52
  SPEAKER_00: We need to unpack the concept of presentation bias.
• 29:55
  SPEAKER_01: Presentation bias is the cognitive trap that ensnares both the patient and the physician.
• 30:01
  SPEAKER_01: It occurs when a patient's primary complaints are entirely somatic physical pain,
• 30:06
  SPEAKER_01: altered bowel habits,
• 30:07
  SPEAKER_01: fatigue,
• 30:08
  SPEAKER_01: And the physician is so blinded by the physical symptoms that they completely fail
• 30:12
  SPEAKER_01: to scream for the underlying affective or anxiety disorder.
• 30:16
  SPEAKER_00: The chapter cite a landmark study by Kryink that quantifies just how dangerous this diet is.
• 30:22
  SPEAKER_00: They look at the total number of physical symptoms a patient presents with.
• 30:25
  SPEAKER_01: The physical symptoms count.
• 30:27
  SPEAKER_00: Right.
• 30:27
  SPEAKER_00: If a patient complains of zero or one physical symptom,
• 30:30
  SPEAKER_00: their probability of having an underlying mood or anxiety disorder is about 4%.
• 30:36
  SPEAKER_00: But if they present with nine or more diffused physical symptoms,
• 30:39
  SPEAKER_00: that probability skyrockets to 78%.
• 30:41
  SPEAKER_01: The physical symptom count is a massive, screaming surrogate marker for psychological distress.
• 30:46
  SPEAKER_00: But the corollary data is where the system fails.
• 30:48
  SPEAKER_00: If a patient presents with nine somatic complaints
• 30:50
  SPEAKER_00: but never explicitly mentions feeling sad or anxious,
• 30:53
  SPEAKER_00: physicians correctly diagnose the underlying psychiatric disorder only 22% of
• 30:58
  SPEAKER_00: the time.
• 30:59
  SPEAKER_01: The medical gaze is far too narrow.
• 31:00
  SPEAKER_00: So how do you widen the gaze without alienating the patient?
• 31:04
  SPEAKER_00: The mantra here seems to be going slow is going fast.
• 31:08
  SPEAKER_00: You mentioned earlier using a symptom diary as a transitional tool.
• 31:12
  SPEAKER_00: Why is that more effective than simply handing them an SSRI
• 31:15
  SPEAKER_00: and telling them they have central sensitization?
• 31:17
  SPEAKER_01: Because an SSRI prescription handed out after a normal colonoscopy just feels like a dismissal.
• 31:23
  SPEAKER_01: A symptom diary empowers the patient to discover the biopsychosocial link themselves.
• 31:28
  SPEAKER_00: How does that work in practice?
• 31:29
  SPEAKER_01: You ask them to meticulously log their bowel movements,
• 31:32
  SPEAKER_01: their pain skulls,
• 31:33
  SPEAKER_01: but also their sleep quality, their conflicts at work, their dietary intake.
• 31:38
  SPEAKER_01: Over a month, the patient returns and sees the data for themselves.
• 31:42
  SPEAKER_01: My pain spiked to a nine the day before my massive board presentation,
• 31:46
  SPEAKER_01: even though I ate perfectly.
• 31:48
  SPEAKER_00: The patient generates their own insight into the gut-brain axis.
• 31:51
  SPEAKER_01: Exactly.
• 31:51
  SPEAKER_01: It provides the crucial foundational buy-in for psychopharmacology
• 31:55
  SPEAKER_01: and cognitive behavioral therapy.
• 31:56
  SPEAKER_00: Let's transition to the heavy artillery then.
• 31:59
  SPEAKER_00: Psychopharmacology.
• 32:01
  SPEAKER_00: This is where I want to push back on the clinical logic.
• 32:04
  SPEAKER_00: Why on earth are we prescribing powerful psychiatric medications,
• 32:08
  SPEAKER_00: antidepressants,
• 32:09
  SPEAKER_00: atypical antipsychotics,
• 32:11
  SPEAKER_00: to a patient who is entirely non-psychotic,
• 32:14
  SPEAKER_00: potentially non-depressed, but has severe stomach cramps?
• 32:18
  SPEAKER_00: It feels like we are just sedating the patient so they stop complaining.
• 32:21
  SPEAKER_01: That is a very common and highly inaccurate criticism.
• 32:25
  SPEAKER_01: We are not sedating the patient and we are not merely treating an incidental low mood.
• 32:29
  SPEAKER_01: We are exploiting the shared chemical language of the access.
• 32:33
  SPEAKER_00: OK, I'm back.
• 32:33
  SPEAKER_01: We are using these agents as central and peripheral neuromodulators.
• 32:38
  SPEAKER_01: The receptor affinities of these drugs make them highly specific treatments for GI dysfunction.
• 32:43
  SPEAKER_00: Walk me through the classes because they're not interchangeable.
• 32:45
  SPEAKER_00: Let's start with the tricycle candidepressants, the TCAs, like amitriptyline or nortriptyline.
• 32:50
  SPEAKER_01: TCAs are arguably the gold standard neuromodulators for severe functional gut pain.
• 32:56
  SPEAKER_01: They possess potent central analgesic properties at doses significantly lower
• 33:00
  SPEAKER_01: than those required to treat major depression.
• 33:02
  SPEAKER_00: That's not a depression dose.
• 33:03
  SPEAKER_01: No, much lower.
• 33:04
  SPEAKER_01: But their peripheral side effect profile is what makes them invaluable.
• 33:08
  SPEAKER_01: TCAs have strong anticholinergic properties.
• 33:12
  SPEAKER_01: They block muscarinic receptors in the gut.
• 33:14
  SPEAKER_01: This actively slows down gastrointestinal transit time and reduces secretions.
• 33:19
  SPEAKER_00: Oh, so a side effect that psychiatrists normally hate severe constipation becomes
• 33:25
  SPEAKER_00: the primary therapeutic mechanism for a patient with IDSD,
• 33:28
  SPEAKER_00: the diarrhea predominant subtype.
• 33:30
  SPEAKER_01: Exactly.
• 33:31
  SPEAKER_01: You are chemically hitting the brakes on a hyperactive bowel
• 33:33
  SPEAKER_01: while simultaneously dampening the central pain response.
• 33:36
  SPEAKER_01: Brilliant.
• 33:37
  SPEAKER_01: Conversely,
• 33:37
  SPEAKER_01: if you have a patient with IBSC,
• 33:39
  SPEAKER_01: the constipation predominant subtype, a TCA would be disastrous.
• 33:43
  SPEAKER_01: It would cause an ileus.
• 33:44
  SPEAKER_01: For IBSC, we pivot to the selective serotonin reuptake inhibitors, the SSRIs.
• 33:50
  SPEAKER_00: Because SSRIs have the opposite peripheral effect.
• 33:52
  SPEAKER_00: They flood the enterochromaffin system with serotonin,
• 33:55
  SPEAKER_00: which acts as a powerful prokinetic,
• 33:57
  SPEAKER_00: stimulating gut motility and relieving the constipation,
• 34:00
  SPEAKER_00: while centrally downregulating anxiety and the hypervigilance associated with
• 34:03
  SPEAKER_00: the condition.
• 34:04
  SPEAKER_01: It requires immense pharmacological precision.
• 34:06
  SPEAKER_01: You have to match the drug to the bowel habit.
• 34:09
  SPEAKER_01: The chapter also highlights the atypical agents.
• 34:12
  SPEAKER_01: Mirtazapine is a brilliant choice for a patient with functional dyspepsia or severe nausea.
• 34:16
  SPEAKER_00: Why mirtazapine?
• 34:17
  SPEAKER_01: Because its potent 5-HT3 receptor antagonism provides profound antiemetic effects,
• 34:22
  SPEAKER_01: while its antihistaminergic properties promote sleep and weight gain
• 34:26
  SPEAKER_01: in malnourished patients.
• 34:27
  SPEAKER_00: What about the antipsychotics?
• 34:29
  SPEAKER_00: The chapter mentions using quichipine for visceral pain.
• 34:32
  SPEAKER_00: If I suggest to a gastroenterology patient that I want to put them on
• 34:35
  SPEAKER_00: an antipsychotic for their stomach ache, they are going to walk out.
• 34:39
  SPEAKER_00: What is the mechanism there?
• 34:40
  SPEAKER_01: You have to frame it purely around receptor logic.
• 34:43
  SPEAKER_01: We use very low doses of quichipine,
• 34:45
  SPEAKER_01: completely divorced from its dopamine D2 blocking effects used in psychosis.
• 34:49
  SPEAKER_00: What receptors is it hitting at that low dose?
• 34:52
  SPEAKER_01: At low doses,
• 34:53
  SPEAKER_01: creatiapine acts primarily as a potent H1 histamine antagonist and
• 34:57
  SPEAKER_01: a 5-HT2A antagonist.
• 34:59
  SPEAKER_01: It rapidly mitigates severe autonomic arousal,
• 35:02
  SPEAKER_01: drastically improves sleep architecture,
• 35:04
  SPEAKER_01: and provides a distinct,
• 35:05
  SPEAKER_01: independent analgesic effect for pain that is entirely refractory to TCAs and SSRIs.
• 35:11
  SPEAKER_00: Okay, but the text introduces an even more radical concept regarding psychopharmacology.
• 35:16
  SPEAKER_00: We discussed earlier how chronic pain
• 35:18
  SPEAKER_00: and psychological trauma cause actual neurodegeneration,
• 35:22
  SPEAKER_00: the thinning of the insula and the anterior cingulate cortex.
• 35:25
  SPEAKER_01: Yes, the structural atrophy.
• 35:27
  SPEAKER_00: The chapter suggests that these neuromodulators aren't just masking pain.
• 35:31
  SPEAKER_00: They're physically repairing the brain hardware.
• 35:35
  SPEAKER_00: Explain the role of brain-derived neurotrophic factor.
• 35:38
  SPEAKER_01: Brain-derived neurotrophic factor,
• 35:40
  SPEAKER_01: or BDNF,
• 35:41
  SPEAKER_01: is a protein that acts as a vital fertilizer for the central nervous system.
• 35:45
  SPEAKER_01: It promotes the survival of existing neurons and encourages the growth
• 35:49
  SPEAKER_01: of new synapses and dendritic spines.
• 35:51
  SPEAKER_00: And necrotic pain.
• 35:52
  SPEAKER_01: In states of chronic severe stress and chronic pain,
• 35:55
  SPEAKER_01: BDNF levels plummet, leading to the cortical atrophy we see on functional MRI.
• 36:00
  SPEAKER_00: So the brain shrinks because it's starved of this growth factor.
• 36:03
  SPEAKER_01: Yes.
• 36:03
  SPEAKER_01: The profound biological revelation is that sustained treatment with antidepressants,
• 36:07
  SPEAKER_01: specifically SSRIs and TCAs,
• 36:10
  SPEAKER_01: rapidly upregulates the transcription and release of BDNF.
• 36:13
  SPEAKER_00: Wait, so the drugs grow it back?
• 36:15
  SPEAKER_01: The pharmacological intervention literally stimulates neurogenesis within
• 36:19
  SPEAKER_01: the central pain matrix.
• 36:21
  SPEAKER_01: We are seeing structural recovery of the cortical gray matter,
• 36:25
  SPEAKER_01: which correlates clinically with a decreased frequency of symptom relapse.
• 36:29
  SPEAKER_01: We are reversing the neurodegenerative damage caused by the chronic pain state.
• 36:33
  SPEAKER_00: That is a phenomenal biological reality.
• 36:36
  SPEAKER_00: But pills are not the only way to alter the axis.
• 36:39
  SPEAKER_00: The chapter details several non-pharmacological interventions.
• 36:43
  SPEAKER_01: Cognitive behavioral therapy is obvious,
• 36:46
  SPEAKER_01: restructuring the catastrophic thinking patterns we saw in the cycle of
• 36:50
  SPEAKER_01: the disenfranchised patient.
• 36:51
  SPEAKER_00: And interpersonal therapy addresses the psychosocial stressors driving the HPA axis.
• 36:57
  SPEAKER_00: But the intervention that genuinely shocked me was gut directed hypnotherapy.
• 37:01
  SPEAKER_01: It sounds esoteric, doesn't it?
• 37:02
  SPEAKER_01: But the empirical data is incredibly robust.
• 37:05
  SPEAKER_01: Gut directed hypnotherapy involves inducing a deep state of relaxation
• 37:09
  SPEAKER_01: and providing highly specific metaphorical suggestions aimed
• 37:12
  SPEAKER_01: at normalizing gut motility and reducing visceral sensitivity.
• 37:16
  SPEAKER_00: It utilizes top-down central processing to enforce peripheral autonomic regulation.
• 37:21
  SPEAKER_00: But the text references a study that takes it out of the functional realm
• 37:24
  SPEAKER_00: and applies it to severe organic disease.
• 37:29
  SPEAKER_00: The Miller and Warwell study involved 15 patients with severe inflammatory bowel disease.
• 37:34
  SPEAKER_00: We are talking about autoimmune, mucosal, ulceration.
• 37:37
  SPEAKER_01: Real, visible inflammation.
• 37:39
  SPEAKER_00: And the hypnotherapy demonstrated such a profound physiological effect
• 37:43
  SPEAKER_00: that it decreased systemic inflammation and allowed more than half of the patients
• 37:47
  SPEAKER_00: to completely cease their corticosteroid therapy.
• 37:50
  SPEAKER_01: It is the ultimate validation of the biopsychosocial model.
• 37:54
  SPEAKER_01: By altering the central processing of stress via hypnotherapy,
• 37:58
  SPEAKER_01: They down-regulated the autonomic nervous system,
• 38:01
  SPEAKER_01: reduced the peripheral release of pro-inflammatory cytokines,
• 38:04
  SPEAKER_01: and achieved a steroid-sparing clinical remission in an organic autoimmune disease.
• 38:09
  SPEAKER_00: The brain healed the gut.
• 38:10
  SPEAKER_01: The brain healed the gut.
• 38:11
  SPEAKER_00: Which brings our conceptual loop to a perfect close.
• 38:14
  SPEAKER_00: The biology is undeniable.
• 38:16
  SPEAKER_00: Now, before we conclude, I want to run a rapid-fire clinical ward round.
• 38:20
  SPEAKER_00: We're going to tense the mental models we've built today.
• 38:23
  SPEAKER_00: I will present a clinical scenario with four options,
• 38:26
  SPEAKER_00: give you a moment to lock in your reasoning,
• 38:28
  SPEAKER_00: and then our expert will dissect the underlying logic.
• 38:31
  SPEAKER_01: Let's run the ward round.
• 38:33
  SPEAKER_00: Scenario one.
• 38:34
  SPEAKER_00: Mechanism.
• 38:36
  SPEAKER_00: Which of the following neurotransmitters or pathways is not primarily implicated in
• 38:40
  SPEAKER_00: the shared bi-directional communication of the brain-gut microbiome axis as detailed
• 38:44
  SPEAKER_00: in the text?
• 38:45
  SPEAKER_00: A, serotonin.
• 38:47
  SPEAKER_00: B, corticotropin releasing factor.
• 38:49
  SPEAKER_00: C, dopamine.
• 38:50
  SPEAKER_00: D, norepinephrine.
• 38:52
  SPEAKER_01: So the answer is C, dopamine.
• 38:54
  SPEAKER_01: While dopamine is absolutely critical and central reward in motor pathways,
• 38:57
  SPEAKER_01: the Chapter S specific architectural model of the gut-brain axis relies heavily
• 39:01
  SPEAKER_01: on serotonin for motility and sensation.
• 39:03
  SPEAKER_01: Nora Pinefern for autonomic tone and CRF as the primary mediator of
• 39:07
  SPEAKER_01: the stress cascade that alters gut permeability.
• 39:11
  SPEAKER_00: Clinical Reasoning in IBD A 28-year-old male
• 39:14
  SPEAKER_00: with highly active Crohn's disease is evaluated on the ward for severe depression.
• 39:19
  SPEAKER_00: According to the large cohort studies,
• 39:21
  SPEAKER_00: what is the exact temporal relationship between his depression and his IBD?
• 39:25
  SPEAKER_00: A. Depression only occurs as a secondary reactive response to the IBD diagnosis.
• 39:30
  SPEAKER_00: B. Depression independently increases the risk of developing IBD
• 39:34
  SPEAKER_00: and exacerbates existing symptoms.
• 39:36
  SPEAKER_00: C. SSRIs are strictly contraindicated as they increase the risk of an IBD flare.
• 39:41
  SPEAKER_00: D, IBD only precipitates depression when patients are on high-dose corticosteroids.
• 39:46
  SPEAKER_01: The formulation points
• 39:47
  SPEAKER_00: to B.
• 39:47
  SPEAKER_00: The 400 and 3,000 patient cohort study definitively proved the relationship is bidirectional.
• 39:53
  SPEAKER_00: The psychiatric state is an independent risk factor for the initial development of
• 39:56
  SPEAKER_00: the autoimmune condition.
• 39:58
  SPEAKER_00: Furthermore, option C is factually incorrect.
• 40:00
  SPEAKER_00: The data suggests the use of SSRIs and TCAs is actually protective,
• 40:04
  SPEAKER_00: mitigating the risk
• 40:04
  SPEAKER_00: of developing IBD via their anti-inflammatory neuroimmunological effects.
• 40:08
  SPEAKER_00: Brilliant.
• 40:10
  SPEAKER_00: Scenario 3.
• 40:11
  SPEAKER_00: Diagnostic Criteria.
• 40:13
  SPEAKER_00: Applying the Rome-SETI criteria,
• 40:15
  SPEAKER_00: irritable bowel syndrome is defined by recurrent abdominal pain associated with two
• 40:19
  SPEAKER_00: or more highly specific features.
• 40:21
  SPEAKER_00: Which of the following is one of those required features?
• 40:24
  SPEAKER_00: A.
• 40:25
  SPEAKER_00: Continuous pain completely independent of physiologic events.
• 40:28
  SPEAKER_00: B.
• 40:29
  SPEAKER_00: Pain temporally related to defecation.
• 40:31
  SPEAKER_00: C. Pain relief achieved with antacids.
• 40:33
  SPEAKER_00: D. Pain co-occurring with fibromyalgia tender points.
• 40:37
  SPEAKER_01: The correct diagnostic feature is B.
• 40:39
  SPEAKER_01: The hallmark of IBS is that the pain is mechanically linked to the gut's action.
• 40:43
  SPEAKER_01: It is related to defecation or a change in stool frequency or form.
• 40:46
  SPEAKER_01: Option A describes centrally mediated abdominal pain syndrome where
• 40:49
  SPEAKER_01: the pain is entirely decoupled from gut physiology.
• 40:52
  SPEAKER_00: Scenario 4.
• 40:53
  SPEAKER_00: Pharmacology application.
• 40:55
  SPEAKER_00: You are consulting on a 40-year-old female presenting with severe IBS.
• 40:59
  SPEAKER_00: Her predominant symptom is intractable constipation,
• 41:02
  SPEAKER_00: so IBS-C. She also meets criteria for generalized anxiety disorder.
• 41:07
  SPEAKER_00: Which psychopharmacological agent is most aligned
• 41:09
  SPEAKER_00: with treating both her central psychiatric
• 41:12
  SPEAKER_00: and peripheral GI symptoms simultaneously?
• 41:14
  SPEAKER_00: A.
• 41:15
  SPEAKER_00: A tricyclic antidepressant like amitriptyline.
• 41:18
  SPEAKER_00: B.
• 41:19
  SPEAKER_00: An SSRI like sertraline.
• 41:21
  SPEAKER_00: C. Clonidine.
• 41:22
  SPEAKER_00: D. Heliperidol.
• 41:24
  SPEAKER_01: The clinical choice is B, an SSRI.
• 41:26
  SPEAKER_01: Central mirror modulation with an SSRI will address her severe anxiety,
• 41:29
  SPEAKER_01: while the peripheral serotonergic effects act as a prokinetic,
• 41:32
  SPEAKER_01: stimulating gut motility and relieving her constipation.
• 41:35
  SPEAKER_01: Optin A, a TCA,
• 41:36
  SPEAKER_01: would be clinically disastrous,
• 41:38
  SPEAKER_01: as its potent anticholinergic effects would halt her transit time
• 41:41
  SPEAKER_01: and massively exacerbate her IBSC.
• 41:43
  SPEAKER_00: Final scenario, clinical phenomenon.
• 41:45
  SPEAKER_00: What specific concept describes the systemic failure of clinicians
• 41:48
  SPEAKER_00: to diagnose underlying anxiety or depression because the patient primarily reports
• 41:52
  SPEAKER_00: a high volume of physical complaints?
• 41:54
  SPEAKER_00: A, central sensitization.
• 41:56
  SPEAKER_00: B, presentation bias.
• 41:57
  SPEAKER_00: C, the disenfranchised cycle.
• 41:59
  SPEAKER_00: D, visceral hypervigilance.
• 42:01
  SPEAKER_01: The phenomenon is B, presentation bias.
• 42:04
  SPEAKER_01: This references the Kroenke data,
• 42:06
  SPEAKER_01: demonstrating that even when a high physical symptom count implies a 78% likelihood
• 42:11
  SPEAKER_01: of a mood disorder,
• 42:12
  SPEAKER_01: the medical gaze is so distracted by the somatic complaints that
• 42:16
  SPEAKER_01: the psychiatric diagnosis is missed almost 80% of the time.
• 42:20
  SPEAKER_00: If any of those scenarios challenged your current framework,
• 42:23
  SPEAKER_00: I strongly encourage you to return to Chapter 27.3 of Kaplan and Sedakis.
• 42:29
  SPEAKER_00: It is dense,
• 42:30
  SPEAKER_00: challenging material,
• 42:32
  SPEAKER_00: but integrating this biopsychosocial architecture will fundamentally change your
• 42:35
  SPEAKER_00: clinical practice.
• 42:36
  SPEAKER_01: It demands that we stop treating organs in isolation and start treating
• 42:40
  SPEAKER_01: the entire interconnected human being.
• 42:42
  SPEAKER_00: To conclude our analysis today,
• 42:44
  SPEAKER_00: Biological,
• 42:45
  SPEAKER_00: psychological,
• 42:46
  SPEAKER_00: and social factors are never competing explanations for gastrointestinal distress.
• 42:51
  SPEAKER_00: They are the exact same integrated circuit.
• 42:53
  SPEAKER_00: The great gut-brain exchange is real,
• 42:55
  SPEAKER_00: it is chemically mediated,
• 42:56
  SPEAKER_00: and chronic dysfunction within it physically and structurally degrades the brain.
• 43:00
  SPEAKER_01: It's all connected.
• 43:01
  SPEAKER_00: But I want to leave you with one final, deeply provocative avenue for speculation.
• 43:06
  SPEAKER_00: We have established that the axis is entirely bidirectional.
• 43:09
  SPEAKER_00: We know that severe depression causes brain atrophy,
• 43:12
  SPEAKER_00: and we know the gut microbiome generates massive amounts of upward signaling.
• 43:17
  SPEAKER_00: So, could the future of frontline psychiatric treatment
• 43:20
  SPEAKER_00: for severe refractory depression bypass the brain entirely?
• 43:23
  SPEAKER_01: Oh, wow.
• 43:24
  SPEAKER_00: Could the next generation
• 43:25
  SPEAKER_00: of psychiatric interventions involve highly specific engineered therapies targeting
• 43:30
  SPEAKER_00: the microbial flora of the lower intestine to cure a disorder of the mind?
• 43:34
  SPEAKER_01: It suggests the next frontier of psychiatry might not be neuroscience,
• 43:38
  SPEAKER_01: but advanced microbiology.
• 43:39
  SPEAKER_00: It is a staggering possibility.
• 43:41
  SPEAKER_00: Keep your mental models flexible, everyone.
• 43:43
  SPEAKER_00: Respect the immense complexity of the biological networks inside us all.
• 43:47
  SPEAKER_00: And I assure you, you will never look at a simple stomachache the same way again.
• 43:51
  SPEAKER_00: Until next time.